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Abstract: The need to quantify physicochemical properties of mineralisation spans many fields. 
Clinicians, mineralisation researchers, and bone tissue bioengineers need to be able to measure the 
distribution, quantity, mechanical, and chemical properties of mineralisation within a wide variety 
of substrates from injured muscle to electrospun polymer scaffolds and everything in between. The 
techniques available to measure these properties are highly diverse in terms of their complexity and 
utility. Therefore it is of the utmost importance that those who intend to use them have a clear 
understanding of the advantages and disadvantages of each technique and its appropriateness to 
their specific application. This review provides all of this information for each technique and uses 
heterotopic ossification and engineered bone substitutes as examples to illustrate how these 
techniques have been applied. In addition, we provide novel data using advanced techniques to 
analyse human samples of combat related heterotopic ossification. 
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1 Introduction 
This review provides clinicians, basic science researchers, and bioengineers with a fundamental 
overview of the techniques available for analysing the physiochemical properties of mineralisation 
in vitro and in vivo. The techniques are discussed with particular, but not exclusive, reference to 
heterotopic ossification (HO). The rationale for this is that HO is an example of biomineralisation 
that spans the clinical and research fields. In addition, HO is currently attracting a huge amount of 
interest due to an increasing prevalence in combat injured patients from Iraq and Afghanistan.[1]  
Many of the analytical techniques used to characterise HO are the same as those used to study 
physiological mineralisation and monitor progression of mineralisation in engineered bone 
constructs. These techniques have evolved from basic structural analysis using histology and 
radiographs to truly advanced biomaterials characterisation modalities, such as multiphoton 
spectroscopy and in vivo Raman spectroscopy. Also, techniques such as ultrasound or magnetic 
resonance imaging (MRI) that were traditionally used to produce structural data have been refined 
to generate data on chemical composition or mechanical properties. This review describes each 
technique (Table 1) and its utility in the investigation of mineralisation. Some of the techniques, 
particularly the more advanced and experimental ones, have not yet been used for the analysis of 
HO or bone tissue engineering. These are discussed with alternative examples from the current 
research literature of how they have been used to analyse mineralisation. Finally, in addition to 
illustrative examples taken from the literature, this review contains novel imaging data from the 
physicochemical analysis of samples of combat related HO. 
1.1 Normal Bone Structure 
Bone is a hierarchically ordered composite structure with organisation from the nano to 
macroscopic scale.[2] By mass, bone is 65% inorganic mineral, 25% organic (cells and proteins), 
and 10% water. The inorganic mineral phase is almost entirely composed of nanocrystalline non-
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stoichiometric HA with various lattice substitutions and trace element inclusions.[3] This so-called 
“biological apatite” has been described as being “poorly crystalline”.[4] 
The protein content of bone is 90% type I collagen, which provides a matrix into and upon 
which the mineral phase is deposited.[5] The direction and arrangement of collagen fibres in bone 
varies according to bone type and anatomical location and is one of the mechanisms of 
anisotropy.[6] Non-collagenous proteins make up the remaining 10% and are grouped into one of the 
following categories: proteoglycans, glycoproteins, small integrin-binding ligand N-linked 
glycoproteins (osteopontin, matrix extracellular phosphoglycoprotein, bone sialoprotein, dentin 
matrix protein-1, dentin sialophosphoprotein, and dentin phosphoprotein), osteocalcin, and 
osteonectin.[7] 
There are three specialised cell populations in bone.[8] Osteoblasts are the product of 
mesenchymal stem cell differentiation and their function is to form bone through the production and 
mineralisation of extracellular matrix. Osteoclasts are multinuclear bone-resorbing cells descended 
from a monocyte/macrophage lineage. They resorb bone through the formation of a sealed 
microenvironment into which they actively secrete protons, chloride ions, and Cathepsin K. 
Together, osteoblasts and osteoclasts form multicellular units to facilitate coupled bone 
remodelling, which is a process controlled by local and systemic signalling systems.[9] During the 
process of bone formation, some of the osteoblasts become trapped in lacunae and change 
morphology to become osteocytes. These specialised cells form a network of interconnected 
processes throughout the bony tissue and are thought to have multiple roles including calcium 
sensing, remodelling control, and strain detection.[10]  
1.2 Normal Bone Formation and Function 
Vertebrates form normal bone through two main mechanisms: intramembranous ossification 
(disorganised woven bone is remodelled into the mature lamellar version) and endochondral 
ossification (mineralisation of a cartilage template by osteoblasts).[11] Mature bone is constantly 
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remodelled along lines of force according to Wolff’s law by multicellular functional units 
consisting of coupled osteoblasts and osteoclasts.[12] Bone functions as a mechanical scaffold for 
weight bearing and is an effector mechanism for muscle contraction.[13] It also acts as an endocrine 
organ, storing calcium and phosphorus, and a haematopoietic organ generating blood components. 
[14] Finally, bone has a protective function to prevent damage to crucial organs such as the brain and 
heart. 
1.3 Heterotopic Ossification (HO) 
HO is a disorder characterised by the formation of highly organised lamellar bone in extra-
skeletal sites. It is a problem that has attracted a significant amount of research interest recently 
despite being first described in the literature many centuries ago.[15] What makes this condition so 
fascinating for biomaterials scientists, and so challenging for clinicians, is the speed and volume of 
generation of highly organised mineralised tissue in ectopic sites. While many tissue-engineering 
approaches struggle to generate even a cubic centimetre of bone, combat amputees have been 
shown to generate up to 250cm3 of bone in a single residual limb.[16] Like mature normal bone, HO 
demonstrates organisation at size scales across several orders of magnitude including ordered 
hydroxyapatite (HA) crystal deposition in aligned collagen matrices, Haversian systems, and bone 
marrow cavities.[17] 
It is important to note that HO is not the only form of pathological mineralisation. Many 
disease processes drive aberrant mineralisation and a wide variety of tissues can be affected: blood 
vessels, heart valves, eyes (band keratopathy), spinal ligaments (ankylosing spondylitis), peripheral 
nerves (neuritis ossificans), dermis (osteoma cutis), and subcutaneous tissue (panniculitis ossificans 
traumatica).[18] While the hard tissue formed in these conditions demonstrates some organisation, it 
is not to the same extent as found in HO (Figure 1). 
Clinical Impact of HO 
  5 
Ossification in soft tissue can cause significant morbidity. Patients with HO suffer from 
pain, ulceration of overlying skin, loss of joint range of movement, and difficulty in fitting limb 
prostheses after amputation.[19] Current preventative treatments include non-steroidal anti-
inflammatory drugs, radiotherapy, and bisphosphonates but these have significant side effects and 
are not always appropriate for severely injured patients.[20] Conservative treatment measures include 
reduction in physical activity, range of movement exercises, pain relief, and prosthetic 
adjustment.[21] However, a significant proportion of patients will require surgery to remove the 
excess bone. In a follow-up study of US military patients with HO, 19% required surgery to excise 
symptomatic ectopic bone.[22] In this cohort, the mean interval from injury to excision was 8.2 
months. Despite the significant burden of morbidity caused by the disease, its prevention, and its 
treatment, there are no documented cases of HO as a direct cause of mortality. 
Epidemiology 
One of the reasons for the increased interest in HO in the literature is that the major conflicts 
in Iraq and Afghanistan have resulted in an unprecedented number of war casualties (Figure 2) who 
have survived high-energy limb injuries and these patients have been shown to have a 65% chance 
of developing HO.[1, 23] The risk factors for developing HO in this patient cohort include amputation 
within the zone of injury, lower limb injuries, increased injury severity, multiple limb injuries, and 
head injury. These risk factors can have a potentiating effect, with one study demonstrating that 
80% of patients with blast amputations developed radiographic evidence of HO within two months 
of injury.[22] Duration of topical negative pressure wound therapy and increased number of 
debridements have been suggested as risk factors but this relationship may be confounded by the 
severity of the original injury.[1] Military trauma is not the only cause of HO. Surgery, civilian 
trauma, burns, spinal cord injury, and traumatic brain injury, can all predispose to the condition 
although the proportion of symptomatic patients and those requiring surgery is lower.[24] 
Iatrogenic HO 
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Special mention should be made of iatrogenic HO as a consequence of bone morphogenic 
protein (BMP) treatment. Increased understanding of the role of BMP-2 in new bone formation led 
bioengineers and clinicians to develop it as a treatment to promote bone union in fractures, non-
union, and joint and spinal fusion. Several products became available using recombinant human 
BMP infiltrated onto an absorbable collagen sponge. However, reports of haematomata, swelling, 
inflammation, and substantial heterotopic bone formation were reported subsequently as adverse 
effects of this treatment.[25] Whether these adverse effects are caused by excessive doses of BMP or 
by the failure of the delivery mechanism (collagen sponge) to contain the active ingredient is 
debatable. It is becoming clear, however, that BMPs also have a central role in genetic and acquired 
forms of HO as discussed below. 
Mechanisms of Formation 
The pathological mechanism of the genetic form of HO known as fibrodysplasia ossificans 
progressiva (FOP) has been studied extensively and is well characterised: a heterozygous single 
nucleotide substitution of arginine to histidine (R206H) in the activin A type I receptor (ACVR1) 
gene.[26] This gene encodes for the protein activin-like kinase 2 (ALK2), which is a receptor for 
BMPs. ALK2R206H has greater sensitivity to the ligand, BMP-2, leading to increased 
phosphorylation and nuclear localisation of Smad proteins, and increased Id1 promoter activity.[27] 
Increased ALK2 activity subsequently leads to increased chondrogenic and osteogenic 
differentiation and the formation of bone in ectopic sites through endochondral ossification. 
Another genetic form of HO is progressive osseous heteroplasia (POH). This is clinically distinct 
from FOP in that the affected patients lack the characteristic preosseous swellings and congenital 
deformities of FOP and have cutaneous osseous lesions and deep heterotopic bone that cross tissue 
and fascial planes.[28]  
In contrast to FOP, POH occurs through intramembranous ossification and its genetic basis 
is less well characterised but is thought to involve heterozygous mutation in the GNAS1 gene.[29] 
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The mutation inactivates the GNAS1 gene, which encodes for the alpha subunit of Gsα, and it is 
thought that this leads to dysregulation of cell lineage switching resulting in excessive osteogenic 
differentiation of MSCs.[30] 
There is significant controversy in the literature about the fundamental cellular and 
molecular mechanisms involved in acquired HO formation.[31] Many different cell populations have 
been implicated in the process of pathological mineralisation including local muscle-derived MSCs, 
recruited circulating MSCs, hypoxic adipocytes, satellite cells, vascular endothelium, and neural 
crest derived pericytes.[32] The evidence does not support all of these cell types to the same extent 
and consensus is building to favour the direct role of multipotent cells of mesenchymal origin.[33] 
There is also significant support in the literature for the central role of an exaggerated inflammatory 
response in the pathogenesis of HO.[34] In terms of the molecular mechanisms involved, recent data 
has shown upregulation in key osteogenic and chondrogenic gene transcripts (BMP2, BMP3, 
ALPL, COLL2A1, COLL10A1, COLL11A1, COMP, CSF2, CSF3, MMP8, MMP9, SMAD1, and 
VEGFA) in soft tissues of high-energy combat wounds.[35] The upregulation of these gene 
transcripts suggests an endochondral model of development of acquired HO, something that has 
been confirmed separately in an animal model.[36] 
Costs 
There are no published data on the direct financial costs of HO. However, some indication 
may be gained from a paper by Masini et al who estimate that the direct cost of disability benefits 
for US service personnel with extremity injury sustained during the campaigns in Iraq and 
Afghanistan between October 2001 and 2005 to be $1.2 billion.[37] Given that, at the time of 
writing, a further 10 years of conflict has elapsed, the true figure is likely to be vastly more than this 
estimation. If 64% of combat extremity injuries develop HO (see above), the proportion of this cost 
estimate that relates to HO prevention, treatment, and rehabilitation is likely to be significant.  
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1.4 Bone Bioengineering 
Bone graft is used in a variety of orthopaedic surgical procedures; examples include spinal 
fusion, fixation of proximal femoral peri-prosthetic fractures, and segmental bone defect filling.[38] 
Typically, either cancellous bone or cortical strut graft is used. Ordinarily, bone graft has to be 
taken from the patient (autograft) or from another person (allograft). Autograft donor site morbidity 
includes pain, infection, scaring, nerve injury, fracture, and haematoma.[39] Allograft is expensive, 
complicated to store and transport, and has risks of rejection and infection.[40] Despite all of the 
problems, autograft remains the gold standard, potentially indicating that the attempts to generate an 
engineered alternative have failed to produce a better alternative.  
In general, bone graft substitutes may be characterised by their scaffold material, signalling or 
therapeutic molecule payload, and cell populations. Not all graft substitutes will have all three 
components, and it is not clear whether all are needed. As the complexity of the material increases, 
so will the cost and risk of adverse effects, negating the point of the substitute in the first place. 
Scaffold 
In its simplest form, bone graft substitute may be entirely scaffold with no additional 
components. Examples of this include inorganic calcium phosphates or calcium sulphates.[41] These 
materials are relatively cheap to produce, transport, and store. They can be formulated into almost 
any shape and size. By combining calcium phosphate phases with differing solubility, the timescale 
to resorption can be tailored to the specific application required. Another benefit is their high 
compressive strength (e.g. HA may exhibit a compressive strength of approximately 300-
500MPa[42]), however they tend to be brittle and are not suitable for full load bearing. There are 
many of these inorganic mineral-based bone substitutes currently available on the market and used 
in clinical practice; chronOS® (beta tricalcium phosphate, Synthes) and Stimulan® (calcium 
sulphate, Biocomposites) for example. Bioactive glass is another example of inorganic scaffold 
material that has been explored but has not, so far, been adopted widely in clinical practice.[43] To 
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overcome the brittleness of both of these materials, bioengineers have explored the use of organic 
polymers (such as polylactic acid, polyglycolic acid, polycaprolactone, and collagen inter alia) or 
even hybrid inorganic/organic materials (polylactide-co-glycolide with bioactive glass).[44] 
Therapeutic Payload 
Bioengineers have also attempted to augment these scaffolds with biologically active 
molecules in order to promote bone regenerate and integration. Indeed, see above for discussion 
relating to the use of collagen sponge scaffold with BMP-2 infiltration. Other molecules relevant to 
bone regeneration have been investigated including fibroblast growth factor, vascular endothelial 
growth factor, platelet-derived growth factor, and platelet rich plasma.[45] 
Cell Populations 
Loading the bone graft scaffold with a population of bone-forming cells seems like a logical 
extension of the concept and a step closer to mimicking autograft.[46] Multiple in vivo experiments 
using animal and human MSCs have supported the efficacy of this approach and several clinical 
examples of implanted HA graft substitute seeded with autologous marrow stromal cells have been 
published.[47] 
All of the experimental work discussed above relates in some way to biological mineralisation 
of a substrate. For some researchers, the goal is to promote mineralisation, for others it is to prevent 
it, and for clinicians there is a need to identify and monitor pathological mineralisation in order to 
make treatment decisions and plan operations. A requirement common to all of them, however, is to 
be able to quantify certain properties of this mineralisation; volume, mineral density, crystal size, 
morphology etc. To divide the techniques according to whether the user was interested in promoting 
or inhibiting mineralisation would be artificial and unhelpful. Furthermore, to divide the techniques 
into research or clinical would be to ignore the rapid translation of what have previously been 
experimental modalities into the clinic. This review is therefore designed to be of use to anyone 
interested in measuring biological mineralisation across all fields. The fact that the authors have 
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used HO and engineered bone tissue substitutes as examples to illustrate the utility and limitations 
of the techniques should not put off those who seek to analyse mineralisation in other conditions or 
constructs, such as bone repair and fracture healing. 
2 Modalities 
Imaging modalities can be divided into those that provide information about the structure, 
chemical composition, or mechanical properties of samples. Some modalities can give information 
on more than one of these domains. 
2.1 Structural Analysis 
2.1.1 Light Microscopy 
Light microscopy covers a broad range of well-established techniques, most of which utilise 
visible light reflected off or transmitted through a sample. This enables direct visualisation of tissue 
or cellular scale structures as a result of differences in their optical properties. The theoretical 
resolution of light microscopy is less than 1µm, since it is limited by the wavelength of light and the 
poor structural contrast of biological samples in their unprocessed form.[48] Light absorption 
contrast may be increased by selectively staining components of interest with chemical dyes.[49]  
Histology remains a very popular modality for investigating mineralisation both in HO and bone 
tissue engineering due to its relative low cost and ability to provide insight into the biological 
response of the surrounding tissue. A significant disadvantage is that histological techniques are 
destructive, as they require the samples to be embedded in plastic or paraffin and then to be 
processed in chemical dyes. Furthermore, processing of mineralised samples requires either 
specialised cutting techniques or a demineralising step, which is to be avoided if the researcher is 
interested in the mineral content. Histological techniques may be combined to provide 
counterstaining to reveal more than one component of interest. 
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While standard hematoxylin and eosin staining may be used, there are many specialist 
histological techniques for imaging mineralisation.[50] One of the oldest is the Von Kossa method, 
which uses a silver nitrate-based treatment that selectively stains the mineralised tissue in a 
sample.[51] In a modification of this staining process, von Kossa tetrachrome, osteoid is also 
visualised in blue as compared to the black colour of mineral. More recent examples are: Alizarin 
red staining of mineralisation in mesenchymal stem cell (MSC) cultures treated with HO wound 
effluent, ex-vivo samples of HO from rodent burn model using Safranin O, Picrosirius Red, and 
aniline blue, Picrosirius red dye used in mouse Achilles tenotomy model, Masson’s trichrome 
staining in examining ex vivo ectopic bone and osteoid formation in dog HO model (ceramic 
implantation), Masson’s trichrome in human combat-related HO samples, and Sanderson’s bone 
stain used to analyse bone and osteoid formation in combat-related HO.[17, 52] 
Immunohistochemical staining is a refinement of light microscopy that allows identification 
of proteins relating to the cell biology of tissues. The principle of this technique is the conjugation 
of a dye molecule to an antibody that will bind to a specific target protein of interest. Fluorescence 
microscopy is then exploited to image the distribution of the labelled antibody without any 
interference from unlabelled background tissue components, and hence a large increase in image 
contrast can be achieved. The protein target could, for example, be a tissue matrix component such 
as collagen or cell surface markers. Cell markers can indicate cell phenotype and stages of cellular 
processes such as proliferation and apoptosis. This offers the possibility to correlate changes in the 
hard tissue matrix to changes in cellular function, which may aid mechanistic understanding of 
different types of mineralisation. A common refinement of this technique is to use one antibody to 
bind to the target and a second, labelled, antibody to bind to the first. In mineralisation research, 
immunohistochemical staining has been used to highlight hypoxia-inducible factor 1-alpha (HIF-1-
α) in a mouse tenotomy HO model and in an in vitro 3D MSC mineralisation model.[53] 
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Examination of the particular cell types within HO or mineralising tissue can also be 
undertaken using selective staining techniques. Osteoclasts can be highlighted by tartrate-resistant 
acid phosphatase (TRAP).[54] Immunohistochemical analysis of alkaline phosphatase will highlight 
osteoblast activity.[33, 55] Staining for lactate dehydrogenase can identify osteocytes and indicate 
viability. 
Fluorochrome labelling is a technique that provides information on the process of 
mineralisation. A fluorescent dye is injected into a live animal or human and acts as a substrate for 
mineralisation or binds to calcium as it is deposited into soft tissue. The tissue/bone sample is 
retrieved after an appropriate interval and analysed under ultraviolet light to reveal the labelled 
newly deposited mineral. The key information to be gained from this technique is the rate and 
location of new mineral deposition. In humans, the antibiotics tetracycline or doxycycline are 
commonly used as fluorochromes. In an animal study on ectopic mineralisation using BMP-loaded 
HA scaffolds, calcein, xylenol orange, and alizarin red have been used to demonstrate the rate of 
mineralisation at different time points.[56] 
2.1.2 Plain radiography and Microradiography 
Plain radiographs are commonly used in clinical practice for diagnosis and surveillance of 
pathological mineralisation. The sample or patient is illuminated with a short pulse of X-rays. The 
detector collects transmitted X-rays attenuated to different extents depending on the elemental 
composition, regional density and thickness of the sample or structures within the sample. Highly 
radio-dense matter, such as calcium in mineralized tissue, absorbs or scatters the x-radiation more 
than less radio-dense components leading to the formation of a “shadow” image on the detector. X-
radiation is ionizing and therefore potentially damaging to live tissue but controlled and sparing use 
can mitigate the risk to acceptable levels. Ex vivo and in vitro samples of mineralising tissue are not 
adversely affected by the low doses of radiation required to form a routine image. Advantages of 
radiography are its relative low cost, rapid acquisition, and suitability for use in vivo. One 
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significant disadvantage is the delay between the start of mineralisation and the time that it becomes 
detectable. For example, after head injury, it takes approximately 4-5 weeks for HO to be detected 
by this method.[57] There is a similar time delay in surveillance of combat-related HO in humans 
and blast-related HO in a rat model.[34, 58] Another disadvantage of plain radiography is that the 
images produced are not spatially resolved in three dimensions making it less suitable for 
quantification of volume of HO or for pre-operative planning. 
Microradiography is used for monitoring calcification ex vivo. The macroscopic technique is 
modified by sectioning the sample, embedding it in a radiolucent material, and placing the sample 
in direct contact with the detector. Isaacson et al used this technique to highlight the 
hypervascularity of HO samples excised from civilian trauma patients.[17] Despite its relative 
simplicity, microradiography can provide information on calcification with a spatial resolution of 
approximately 10µm.[59]  
2.1.3 Electron Microscopy 
Electron microscopy relies upon the smaller (de Broglie) wavelength of electrons than light 
to provide higher resolution images than is possible using visible light. Scanning and transmission 
microscopy are able to produce structural and chemical information relevant to mineralisation 
research. The structural information is discussed here. For the chemical techniques, see sections 
2.2.1 and 2.2.2 below. 
Transmission Electron Microscopy (TEM) 
TEM is an imaging technique used to determine the shape and surface structure of thin 
samples with Angstrom-scale lateral resolution. The physical principle behind image contrast in 
TEM depends on the mode of operation, but the most common mode (and the mode used to observe 
the shape of HA crystals) is called ‘bright-field’ mode. In this mode, the electrons can be treated 
under classical physics principles as being occluded or absorbed by the sample. Image contrast is 
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then obtained because fewer electrons are transmitted through thicker regions (or regions containing 
elements of higher atomic number) compared with thinner regions, (or regions containing elements 
of low atomic number) which appear as dark and bright regions in the image respectively. The 
image formed at the detector can then be regarded as a 2D projection of the volume of the sample 
irradiated by the electron beam. The power of TEM resides in its ability to overcome the diffraction 
limits imposed on light microscopy systems. A generalised approximation of the Abbe diffraction 
limit states that the size of the smallest sample feature resolvable using an optical system is 
approximately equal to half the wavelength of the light. The De Broglie wavelength of electrons at 
accelerated by the typical kV voltages used in TEM instruments would be under 1nm, which is 
several hundred times smaller than the wavelengths typically used in light microscopy (e.g. 532nm 
green laser line). It then becomes clear that TEM can resolve features in the pm-nm range and 
achieve atomic scale resolution, which cannot currently be achieved with light microscopy 
techniques. Consequently, TEM is suited to elucidating the mechanism of mineralisation at the 
nano-scale due to its ability to resolve individual mineral crystals.[60] The utility of this technique is 
enhanced by the use of uranyl nitrate staining to reveal the repeating structure of collagen fibrils 
thus allowing direct imaging of the interaction between the mineral and organic components of 
ectopic bone. Scaglione et al used TEM to define the deposition and orientation of collagen into HA 
scaffolds that had been loaded with MSCs and implanted ectopically in a murine model.[61] This 
insight allowed them to infer the mechanisms behind the observed differences in the bone produced 
by each scaffold. 
 The main drawback to using TEM techniques in general is the extensive sample preparation 
required to produce sectioned samples thin enough to be electron transparent and obtain good image 
contrast. As with any chemical or physical sample preparation process, there is the risk of altering 
the natural physical structure of the sample. Although this can be mitigated to an extent by 
cryofreezing samples, this process also requires a specialist TEM setup with a cryostage and the 
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appropriate sample preparation equipment close to hand. Given the level of sample preparation 
required and low sample throughput, TEM may lend itself best as an end stage nanoscale structural 
analysis tool for samples known to contain evidence of early mineral formation rather than act as a 
‘screening process’ to detect mineral in bulk samples. 
Scanning Electron Microscopy (SEM) 
SEM is used to provide information on the topography of a sample surface through the back 
scattering of electrons or the generation of secondary electrons. Secondary electron mode is the 
most common imaging mode found on SEM systems and involves the production of high energy 
electrons ejected from the surface atoms of the sample upon excitation by the incident electron 
beam. The intensity of the secondary electrons reaching the detector is strongly dependent on the 
angle of the sample plane probed by the incoming beam relative to the plane of the detector and 
therefore samples with large changes in topography will produce large changes in image contrast. 
The fine lateral resolution of this technique (around 1nm) and a large depth of field make SEM 
particularly suited to imaging three-dimensional engineered constructs or trabecular structures 
within bone. As an example, SEM has shown utility in evaluating calcium phosphate coating and 
biomineralisation of an electrospun polycaprolactone model in an in vitro study of ectopic 
mineralisation.[62] It has also been used recently to analyse the microarchitecture of calcium 
phosphate ceramics before implantation into rats, rabbits, and dogs as part of an ectopic ossification 
model.[52d] In addition to the insights gained through TEM (discussed above), Scaglione et al used 
SEM to define microarchitecture, and pore size and shape of their scaffolds before seeding with 
MSCs.[61] Once the scaffolds had been seeded with MSCs but before they were implanted into the 
murine model, they were able to demonstrate that a certain scaffold architecture caused polarisation 
of the cells with subsequent alteration in their bone extracellular matrix deposition behaviour.  
Backscattered electron imaging modes detect the reflection of beam electrons scattered 
elastically after interaction with atoms in the specimen interaction volume. The image contrast is 
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strongly dependent on the atomic number of the elements present within the sample. This 
relationship enables good contrast to be obtained of sample with very small changes in topography 
(of the order of 10’s-100nm) and biological samples, which typically consist of light elements or 
elements close together in terms of their atomic number. This imaging mode is often used to 
identify chemical elements within the sample by analysing the characteristic X-ray emission from 
the elements when irradiated by the incident electron beam.  
Backscattered SEM of ex vivo samples of combat related HO has provided data on the 
maturity of the trabecular structure.[17] Surface details over several orders of magnitude down to the 
nanometre scale can be detected which makes it particularly suited to studying the lamellar 
organisation of bone.[63] Figure 3 shows SEM images of samples of combat related HO. These 
images demonstrate the large depth of field and high magnification possible using SEM. These 
images also show the utility of SEM in generating images that are amenable to descriptive analysis; 
for example the demonstration of disordered micron-scale architecture and profuse scalloping, 
possibly due to extensive remodelling by osteoclasts. 
 One of the key advantages of SEM is its versatility in terms of rapid image acquisition over 
a huge range of magnifications and choice of systems available to accommodate biological samples. 
Traditionally, SEM samples require sputter coating of a thin layer of conductive metal in order to 
electrically ground the sample during imaging and prevent artefacts due to charge build up on the 
surface. Biological samples usually require chemical fixation prior to surface coating. Sputter 
coating processes may physically alter delicate and/or thin biological samples such as muscle 
sections but can be avoided by using a low voltage mode in some SEM instruments while 
maintaining a good lateral resolution and contrast. Alternatively, samples can be infused with 
substances such as osmium tetroxide, which improves the bulk conductivity of the sample. 
Environmental SEM enables characterisation of wet uncoated samples by maintaining a suitable 
pressure around the sample. The risk of sample damage from chemical fixation or coating is thus 
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avoided but this comes at the penalty of restricted field of view as the electron beam becomes 
increasingly attenuated the further away the sample is. While electron induced damage/chemical 
changes to samples may be a risk in any form of electron microscopy, the use of a gaseous sample 
environment in ESEM adds a further factor to the issue. To date, the precise impact of electron-gas-
sample interactions are largely unknown, but should be taken into consideration when analysing 
imaging or spectral data. 
 For the analysis of samples relevant to bone engineering and bone disease, the choice of 
technique and whether the use of extensive chemical processing methods is acceptable depends 
largely on the nature of the sample and what information one wishes to extract from that sample. 
Samples consisting of largely of hard matter such as excised bone or bone substitute are likely to be 
more robust against dehydration compared to soft tissues and hence the full range of SEM 
techniques are available to gain high-resolution images of sample microstructure. On the other 
hand, the impact of sample preparation techniques on samples containing a mix of hard and soft 
tissues/materials is likely to be varied. Some reports suggest that chemical fixation of cells and soft 
tissues may induce precipitation within the sample, which is obviously a concern if investigating the 
presence and composition of small mineral or amorphous deposits in the soft tissue components of 
samples.[64] 
 Despite these considerations, SEM offers a powerful tool for studying samples’ physical 
structure and the most promising frontier in this field is the development of systems capable of 
acquiring and co-registering SEM data with optical fluorescence and X-ray imaging data. Although, 
to the best of our knowledge, such an approach has been untested on mineralisation samples under 
discussion in this review, the concept has the potential to remove the number of sample preparation 
and handling steps between imaging with different modalities and hence aid the preservation of 
such samples. 
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2.1.4 Computed Tomography 
The principle of computed x-ray tomography (CT) involves the use of X-rays to illuminate 
the target and a detector to measure the intensity of the transmitted X-rays. The key is that there is 
relative rotational movement between the sample and axis of the radiation such that an image-
processing computer can build up a 3D dataset of radiodensity within the sample. Calcium 
phosphate in bone is relatively radiodense compared with surrounding soft tissue so this technique 
is well suited to detecting mineralisation in in vivo, ex vivo, and tissue engineering applications. A 
potential problem with CT is that the dose of ionising radiation received by the sample is much 
higher than with plain radiography due to the need to illuminate from many directions. However 
this does not prevent this technique from being used in clinical practice, in vitro culture, or in vivo 
models. Clinically, CT remains a common modality for the classification and diagnosis of HO and 
pre-operative planning for its removal.[65] Micro CT utilises exactly the same physical principles as 
clinical CT but at much higher resolution (less than 10µm3).[66] Porter et al used micro CT to 
monitor cell-mediated mineralisation in a perfusion bioreactor and demonstrated that this modality 
could be used in a tissue engineering application without detrimental effects to the cell culture 
under study.[67] One particular advantage of CT is that the dataset can be used to quantify the 
volume of bone formation in all types of mineralising construct including in vitro scaffolds, to in 
vivo lesions, and ex vivo samples.[50, 53a, 54, 62, 68] This is because CT can generate high contrast 
between hard and soft tissues meaning that relatively simple image thresholding-based methods can 
be used to segment the mineralised regions for analysis. Ultimately, being able to quantify exactly 
how much bone has been formed or inhibited is the single most important question to answer in 
most translational biomineralisation studies. Another major advantage of CT is that it can be used to 
monitor ossification serially over time. This has clear beneficial implications for the numbers of 
animals or samples required for experiments in this field. Two recent studies by Peterson et al 
demonstrated this longitudinal monitoring of HO in mouse in vivo implantation models.[52b, 52c]  
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Another major benefit of CT is its ability to demonstrate both surface and cross-sectional detail as 
shown in Figure 4. This three-dimensional micro CT reconstruction of a sample of combat-related 
HO reveals the disordered structure with morphological features of both cancellous and cortical 
bone. The versatility of this technique in being able to generate striking visual images in addition to 
quantitative information, such as histomorphometric or bone mineral density data makes it a very 
powerful tool in mineralisation research. 
2.1.5 Isotope Bone Scanning 
Isotope bone scanning is mentioned here for completeness as it has become less commonly 
used in clinical practice since the advent of other modalities, such as CT. It has not been used 
extensively in recent research literature for analysis of ectopic ossification or bone tissue 
engineering. The principle of this technique involves the administration of a radioisotope (usually 
technetium-99m conjugated to a bisphosphonate) that will localise to areas of metabolic bone 
activity. The radioisotope produces gamma radiation that is detected by a “gamma-camera”. This 
technique is able to detect HO as soon as 2.5 weeks post injury but with the caveat that it is highly 
non-specific. Infection, tumour, thrombosis, and fracture can all provide false positive results.[69] 
2.1.6 Near Infrared Fluorescence 
Near infrared (NIR) light covers the wavelength range of 700-1000nm and has two key 
properties of relevance to in vivo imaging: i) these wavelengths induce little to no auto-fluorescence 
in biological samples and, ii) tissues generally have a low molar attenuation coefficient in the NIR 
range.[70] Good tissue penetration depth and high signal to noise ratio can be achieved when 
transmitting NIR through tissue and NIR-emitting dyes are therefore excellent reporter molecules 
for tissue structures for in vivo or intra vital imaging. Generally, NIR imaging systems consist of a 
NIR source in transmission or reflection geometry with a sensitive CCD camera or an InGaAs 
detector (for less sensitive measurements but over the full NIR range). NIR dyes can be conjugated 
to chemical species that will highlight sites of mineralisation in a manner similar to fluorochrome 
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labelling. Pamidronate has been conjugated with an infrared fluorophore to demonstrate 
development of ossification in a nude mouse model.[71] A particular benefit of this technique in the 
context of monitoring ectopic mineralisation is that is it able to demonstrate mineralisation in its 
very early stages. Figure 5 demonstrates the use of NIR spectroscopy in a rat Achilles 
tenotomy/burn HO model.[72] The probe in this case was a calcium-chelating agent conjugated to an 
infrared fluorescent dye and this system was able to detect HO five days post injury, compared with 
five weeks for micro CT in the same model. This sensitivity to very early ossification could be 
extremely useful in in vivo experimentation as the ability to quantify mineralisation at much earlier 
time points would have a beneficial effect on animal welfare. However, while this technique may be 
able to detect mineralisation much earlier than micro CT, its spatial resolution is much lower and it 
does not produce a three-dimensional dataset. 
2.1.7 Magnetic Resonance Imaging (MRI) 
MRI is a technique widely used in clinical practice and also, to a limited extent, in 
biomaterials science. This technique utilises a constant, strong magnetic field (0.5-1.5 Tesla in 
clinical settings) to align the spin axis of hydrogen nuclei parallel to the direction of the applied 
magnetic field.[73] A radio-frequency pulse is applied perpendicular to the magnetic field, causing 
the spin axis of the nuclei to tilt away from the direction of the magnetic field. Upon cessation of 
the pulse, the spin axis of the hydrogen nuclei realigns to the magnetic field, in a process called 
relaxation, causing radio frequency energy to be emitted and detected by receiver coils. Spatial 
encoding of the data is achieved by employing a secondary gradient coil, which manipulates the 
strength of the magnetic field across the subject such that only nuclei within a given ‘slice’ are 
forced to align with the magnetic field and respond to the radio-frequency pulses. Sequential 
movement of the slice under analysis along the length of the subject then permits the building of a 
three-dimensional data set. Altering the timing, frequency, and intensity of the radio frequency 
pulses, allows encoding of different structural information.  
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One of the main benefits of this technique is that it is non-destructive and requires no 
sample preparation. It has the further advantage that it does not expose the sample to ionising 
radiation. These attributes would seem to make it ideal for monitoring progression of mineralisation 
in animal models but the cost, complexity, and long scan times have been inhibitory to its routine 
use. 
Sites of developing HO in humans have been shown to have the following characteristic 
features on MRI: diffuse muscle hyperintensity on T2 weighted images (which enhances with 
contrast), enhancing hyperintense surrounding fascia, and non-enhancing foci within the muscles 
that were later shown to indicate the origin of mature HO.[74] As HO matures, T1 imaging shows 
areas within the lesion that have low signal intensity (relative to muscle) diminishing while areas 
isointense to muscle increased.[75] Signals indicating fat and cortical bone within the lesion become 
more intense. On T2 images, the intensity of the signal, which is initially high, decreases with 
maturity. However, some authors have questioned the specificity of MRI in the early stages as it 
can mimic infection (abscess, osteomyelitis), fat, and tumour.[76] Several groups have published 
further evidence of the heterogeneity of HO as seen on MRI with the only common characteristic 
linking their cases being a low-intensity rim around the lesion, which is contradictory to previous 
reports.[77] Further, there is evidence that MRI grossly underestimates the presence and extent of 
ossification with only 10% of bony lesions being detected in one study.[75] MRI has been shown to 
be useful in the initial stages of analysis of mineralisation in implanted tissue-engineered structures 
(Figure 6) but the signal becomes less intense as the mineralisation progresses and no additional 
data is provided that could be generated by simpler means.[78] One method for improving the 
specificity of MRI for bone mineral is to conjugate gadolinium, an MRI contrast agent, to a 
bisphosphonate.[79] The bisphosphonate adsorbs onto the surface of HA collocating the gadolinium. 
In explanted polymeric scaffolds seeded with osteoblasts, MRI sensitivity was improved by using a 
gadolinium-alendronate conjugate marker.[80] One of the benefits of this technique is that it 
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counteracts the image-degrading effects of ingrowing blood vessels in implanted bone constructs in 
animal models. MRI is also safe and effective for use in animal models. Several studies have used 
MRI to quantify mineralisation in bone graft substitute implanted ectopically in a rat model.[81] 
Further, MRI microscopy has been used to evaluate the mineralisation of tissue-engineered 
phalange constructs implanted into athymic mice.[82] 
MRI elastography is an experimental technique demonstrating how modalities that have 
previously generated only structural data may be modified to allow analysis of material properties 
of mineralising constructs. As an example, micro MRI elastography has been used to infer the 
tensile strength and elasticity of a mineralising tissue engineered osteogenic cell culture.[83] The 
possibility of using a non-invasive technique to infer mechanical properties has major implications 
for studying mineralisation in bone graft substitutes that have been populated with cell cultures. 
This is because traditional mechanical testing is incredibly challenging to carry out in the sterile 
environment required for cell culture techniques. Another advantage is that this methodology of 
mechanical testing is non-destructive and may be more appropriate for immature cell-infiltrated 
scaffolds. 
2.1.8 Ultrasound 
Ultrasound is an established imaging modality in clinical practice and provides structural 
information based on tissue transduction and reflection of high frequency sound waves. This 
modality is based on electrically driven high-frequency (>20 kHz) oscillation of a piezoelectric 
crystal in the transducer probe. These oscillations are conducted via a coupling gel to the tissue of 
interest. Inside the tissue they are transmitted, refracted, diffracted, or reflected depending on the 
sound conducting properties of the tissue and the interfaces between tissues with differing 
conductive properties. The reflected sound wave is received by the probe and interacts with the 
piezoelectric crystal to generate an electrical signal pulse. The magnitude of this pulse and the time 
taken to travel back to the transducer is recorded and correspond to the impedance mismatch at the 
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reflecting boundary between two tissue types and the depth of that boundary within the body 
respectively. In practice, the probe consists of an array of piezoelectric crystals, enabling processing 
of data from a two-dimensional plane or three-dimensional volume and conversion into an 
image.[84] Ultrasound has the advantages of being relatively cheap, safe, non-destructive to samples, 
and can provide real-time information. One disadvantage is that it is highly user dependent meaning 
that there is often poor correlation between results obtained by different operators.[85] In clinical 
practice, ultrasound has been used to diagnose HO before calcification becomes appreciable on 
plain radiographs or CT.[86] This is possibly due to the change in stiffness of soft tissues observed in 
what has been termed “pre-HO”.[87] HO is recognised using ultrasound by characteristic “zone 
phenomenon”: outer sonolucent muscle zone, highly sound-reflective middle zone of 
mineralisation, and hypoechoic central zone.[86c] Clinically, the use of Doppler ultrasound has a 
secondary advantage in that as well as being able to diagnose HO, it may be used to rule out venous 
thromboembolism, which is a dangerous and common differential diagnosis of early HO in its 
inflammatory phase. Ultrasound has been used to monitor the progression of HO in patients with 
central nervous system injury, showing strong correlation with histological findings.[86d] This study 
also used the Doppler shift of reflected sound energy to demonstrate vascular ingrowth into the new 
area of ossification. This may be of use in animal models of HO formation and in tissue engineering 
applications when researchers want to monitor scaffold implantation.  
Ultrasound also has a role in in vitro mineralisation research. A novel ultrasound technique 
for analysis of mineralisation within a 3D scaffold has been developed.[88] In addition to high-
resolution structural information (25μm), this technique provides data on concentration, 
distribution, and particle size of the mineral phase. Mineralisation can be monitored in an animal 
model using ultrasound.[89] Researchers implanted mesenchymal stem cell-seeded 3D matrices into 
rats and were able to follow the osteogenesis, degradation, and calcification of these constructs over 
time. These techniques are still relatively uncommon in research practice but given that ultrasound 
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does not rely upon ionising radiation and requires no sample preparation, it may become more 
ubiquitous in future. 
2.2 Chemical Analysis 
2.2.1 Selected Area Electron Diffraction (SAED / SAD) 
This technique is an adjunct to TEM which exploits the fact that the de Broglie wavelength 
of a high energy electron beam is orders of magnitude smaller than the typical atomic spacing in a 
crystalline material, leading to electron diffraction by the crystal structure.[90] A fraction of the 
incident electrons are scattered at a particular angle, which relates to the spacing between atoms in a 
particular plane of the sample, and shows as a series of ordered bright spots in an image. Rotation 
of the sample relative to the incident electron beam enables diffracted electrons from a range of 
angles to be detected sequentially to build a diffraction pattern covering a range of crystal planes. 
This pattern is unique to the composition and structural phase of the crystalline material within the 
sample. A ‘selected area’ of the sample is analysed simply by placing a thin metal strip with a small 
aperture underneath the sample to block all electrons except those coming from the region of the 
sample directly above the aperture. A significant advantage of this technique over x-ray diffraction 
is that it can be used to analyse a several hundred nm portion of a sample (microns) in contrast to 
bulk sampling. This is ideal for tissue samples containing small amounts of mineral whereas X-ray 
diffraction usually requires large (mg-1g) amounts of the material of interest to generate good 
diffraction patterns. This modality can provide information on the identity of crystalline species 
present in a sample. For example, Hong et al used it to confirm the identity of crystals in murine 
bone as HA.[60a] Nudelman et al used SAED to demonstrate that the initial infiltration of calcium 
phosphate into mineralising collagen fibres is amorphous and that the characteristic diffraction 
pattern of HA develops later.[91] In the field of tissue engineering, SAED can be used to investigate 
the interface between implanted bone graft substitutes and host bone. De Aza et al implanted 
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bioactive glass/ceramic composites into a murine model and used SAED to demonstrate the 
presence and crystal orientation of HA in newly deposited collagen at the interface region.[92] 
2.2.2 Energy Dispersive X-ray Spectrometry (EDX) 
This modality is another adjunct to electron microscopy whereby high-energy electrons 
strike a sample causing the ejection of electrons in lower energy shells. X-ray radiation is emitted as 
an electron in an outer shell moves to fill the gap. Each different element produces a unique series 
of peaks on an X-ray emission spectrum. A major advantage of this technique is that it provides 
quantitative evidence to corroborate qualitative interpretation of electron microscopic images. For 
example, this technique has been used to confirm the pattern of calcium and phosphorus deposition 
in mineralising horse-tendon collagen fibrils and the distribution of mineralisation on a synthetic 
collagen sponge.[91, 93] Data processing techniques even allow two-dimensional mapping using this 
technique. For example, Koburger et al used it for phosphate mapping of mineralisation of the 
engineered hard-soft interface and Sasaki et al used it to confirm the distribution of calcium and 
phosphorus in a MSC populated cell scaffold.[53b, 94] Finally, as an example of the complementary 
use of SEM, SAED, and EDX to provide structural and chemical information in a mouse model of 
ectopic mineral deposition, see Kikkawa et al.[95] This group were able to determine the location of 
mineral deposition within muscle bundles, confirm that it was a calcium phosphate, and compare 
with the diffraction pattern to pure HA. 
 Limitations of EDX relate to how the nature of the sample can influence the detected 
emission spectrum. X-ray fluorescence will be emitted in all directions, with a portion of this 
reaching the detector. A proportion of these X-rays will not leave the sample due to scattering 
events or attenuation and the influence of these effects on the detected signal depends on the energy 
of fluorescent X-ray and the density and thickness of the material the X-ray must pass through. This 
can be a particular problem in rough samples where thicker regions are likely to attenuate the X-ray 
fluorescence signal more, reducing the signal-to-noise ratio and hence compromise accuracy of 
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element identification. With respect to bone mineral research, this could pose a particular issue 
when attempting to characterise ion substitutions in mineral (which are typically in a few %wt in 
abundance in small sample volumes) or when attempting to resolve chemical composition of intact 
HO samples to preserve the microstructure. 
2.2.3 X-Ray Fluorescence Spectrometry (XRF) 
Similar in principle to energy dispersive x-ray spectrometry (above), XRF can identify 
elements in a sample through the generation of X-ray spectra. However X-rays, rather than 
electrons, are used to excite the sample and such measurements are performed in lab/benchtop scale 
instruments often operated under ambient conditions. Much finer chemical sensitivity (femtogram 
quantities) can be achieved with this technique compared with energy dispersive X-ray 
spectrometry, particularly if the beam is synchrotron generated.[2] Relatively recent advances of this 
technique have included the ability to focus the incident X-rays to a microscale spot and raster over 
the sample surface, enabling elemental mapping with lab/benchtop grade XRF instruments. XRF 
analysis in this manner requires little to no sample preparation and fresh tissue samples can be 
analysed without any noticeable drying due to heating from X-ray exposure. Stahler et al used 
micro-XRF to map abnormal mineralisation by demonstrating low calcium and phosphorus signals 
in chick embryo tibiotarsi.[96] 
 Synchrotron-based XRF measurements and mapping utilise X-ray sources orders of 
magnitude brighter than the X-ray sources typically used in lab grade instrument, which further 
enhances the lower limit of detection of elements. The ability to continuously control the incident 
X-ray beam energy and spectral resolution opens up a more refined subdivision of techniques 
known collectively under the term of X-ray Absorption Spectroscopy. A detailed discussion of such 
methods is beyond the remit of this review, but they essentially probe electron scattering effects at 
energies around the X-ray absorption edge of elements as a means of investigating the covalency, 
electronic structure, oxidation state and site symmetry of elements and compounds within a sample. 
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Thus such methods go beyond identification of elements and into reaction dynamics of elements 
within their sample environment. 
The application of XRF to bone tissue engineering and HO research has so far been limited 
in scope. Typically, its use has been bulk measurement of calcium phosphate ratios in pre-
implantation ceramic materials.[97] However, an example of a more advanced application is the use 
of synchrotron XRF to produce elemental mapping of zinc and calcium in a rabbit zinc-doped HA 
implantation model.[98] XRF provided data to demonstrate the post-implantation distribution of this 
element. Thus elemental mapping using XRF is demonstrated to be an excellent technique for 
mapping the fate of the constituents of doped or substituted calcium phosphates being used as bone 
grafts. 
There are currently no published studies using mapped XRF to investigate elemental 
distribution in samples of HO. Figure 7 is an example of how XRF may be used to map the 
distribution of calcium and phosphorus in a sample of combat-related HO. Calcium rich projections 
can be seen at the edge of islands of mineral deposition. This suggests that the mechanism of 
mineralisation involves the initial deposition of calcium-rich phases prior to maturation into apatitic 
mineral. Importantly, this kind of enhanced understanding of the chemical nature of pathological 
bone maturation aids in directing the development of therapeutic approaches towards targeting less 
thermodynamically stable calcium phosphate phases. 
In terms of limitations, care must be taken to consider how the sample topography and 
thickness may influence the XRF spectrum/elemental map in much the same way as EDX, albeit to 
a lesser extent. Some signal will still be lost within the sample but this can be partly offset by using 
the more intense X-ray based sources associated with XRF to create more excitation events in the 
sample per unit time. The depth penetration of XRF depends on the elements under investigation 
and the intensity of the incidence beam with general penetration ranging from 10’s-100’s of µm. As 
a result, this is still largely a surface based technique in the context of bone samples and does not 
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afford depth resolved chemical mapping. Micro-XRF instruments have a very small depth of field 
and hence only regions of a sample surface within a few hundred micron window range of the 
detector will mapped accurately. For samples with large undulations (mm), this could simply be 
overcome by bringing the sample closer or further away from the detector. 
2.2.4 Fourier Transform Infrared Spectroscopy (FT-IS / FT-IR) 
Infrared (IR) light can be absorbed by molecules within samples to cause stretching, 
twisting and rocking modes of their chemical bonds. The frequencies of light required to resonate 
with such modes are highly dependent on the constituent elements of a molecule and, unlike X-ray 
fluorescence spectrometry, the nature of the bonding between those elements. A broadband IR 
beam incident on a sample may resonate with multiple modes of several different chemical bonds 
creating a spectrum of well-defined absorption peaks unique to the molecule. FT-IR is most 
commonly used to produce spectra for bulk samples but recent advances have meant that it can 
produce two-dimensional mapped data and even, using the confocal principle, a three dimensional 
data-set in a non-destructive manner. Using a standard IR emission source, spatial resolution is in 
the region of 10μm, but this may be reduced to 1.3μm by illuminating the sample with a 
synchrotron unit.[99] FT-IR data can provide the following spatially-resolved information for 
mineralized tissue samples: mineral content, carbonate/phosphate content, crystallinity (see Figure 
8), the type of carbonate substitution, the relative acid phosphate content, and collagen maturity.[99] 
In bone graft substitute bioengineering, FT-IR has been used to map the spatial distribution of HA 
and poly(dl-lactide) in a bioglass-loaded composite foam.[100] FT-IR has also been used to 
demonstrate the evolution of calcium phosphate crystal phases in sites of heterotopic ossification in 
a mouse model.[101] This technique has yet to be used to analyse the chemical bonds present in 
human HO but given how valuable it has been in providing insights into physiological 
mineralisation, much may be gained by doing so. 
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2.2.5 Raman Spectroscopy 
Raman spectroscopy has revolutionised the compositional analysis of samples in 
ossification research. Monochromatic laser light is used to illuminate the sample and is scattered 
inelastically by the chemical bonds within molecular species present, resulting in a shift in the 
wavelength of the light.[102] A chemical bond between two elements produces a unique wavelength 
shift of the incident light, which is detected as peak on a plot of Raman intensity against 
wavenumber, and hence mineral and collagen have distinct patterns of Raman peaks. Depending on 
the species present, Raman spectroscopy is also sensitive to the chemical coordination around the 
bond of interest and orientation of the molecule within the sample matrix. Raman mapping can be 
performed by rastering a diffraction-limited laser spot over the sample surface and collecting a 
Raman spectrum at each point. The integrated intensity under a peak relating to a molecule of 
interest produces a grey level pixel value and hence changes in the image intensity representing 
differences in the abundance of that particular molecule across the sample. Lateral resolutions are 
defined by the Abbe diffraction limits and hence have a theoretical resolution of the order of half 
the wavelength of light used. However, in practice, 1µm is the limit of resolution of this technique 
and analyte sensitivity is in the nanogram range.[103] Three-dimensional chemical maps can be 
obtained by raising or lowering the sample with respect to the objective lens after rastering each 
plane in the same way as confocal fluorescence microscopy. One major advantage of Raman 
spectroscopy for analysis of biological samples is there is minimal interfering signal from water, in 
contrast to FT-IR. Additionally, Raman spectroscopy can be considered a complimentary technique 
to FT-IR in that it can analyse transitions such as those exhibited by centrosymmetric molecules. 
The spectra generated by Raman spectroscopy show peaks unique to molecular bond bending, 
vibration, and rotation. In bone, the ν1 phosphate vibration at 961cm-1 is the predominant peak with 
others at 438cm-1 (ν2 phosphate), 589cm-1 (ν4 phosphate), 1075cm-1 (carbonate substitution), 
1256cm-1 (amide III in collagen), 1677cm-1 (amide I in collagen).[102] Raman spectroscopy has been 
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used to demonstrate that ectopic bone in a mouse burn model is compositionally identical to normal 
cortical bone.[52b] Potter et al used Raman spectroscopy to detect “pre-heterotopic ossification” in 
combat injured muscle by the appearance of mineral bands at 961 cm-1.[52a] The same group 
undertook a more detailed analysis of combat-injured tissue using this technique to demonstrate the 
early deposition of type I collagen followed by the appearance of mineralisation.[87] The maturation 
of mineralisation was then monitored spectroscopically by the reduction in the ratio of amorphous 
calcium phosphate to HA. This suggests that Raman spectroscopy may have a clinical role in the 
minimally-invasive detection and monitoring of HO, a concept supported by a recent pilot study by 
Harris et al.[104] Evidence that this concept is viable in living tissue is provided by Peterson et al 
who used transcutaneous Raman spectroscopy to detect HO progression in a live mouse model.[52c] 
This paper reports that HO may be detected as early as 5 days post injury using in vivo Raman. 
Ghita et al have shown that Raman spectroscopy is also a viable technique for prolonged in vitro 
monitoring of mineralising cell culture.[105] Over 28 days of culture they demonstrated the 
conversion of amorphous calcium phosphate into HA. Using a confocal Raman system, we have 
been able to demonstrate the spatial distribution of amorphous and apatitic calcium phosphate at the 
leading edge of a projection of mineralisation in a sample of combat related HO (Figure 9). The 
data shows a projection with a central core of collagen surrounded by colocalised HA and 
amorphous calcium phosphate. 
 In terms on future prospects for Raman mapping and spectroscopy in the field on bone 
mineral research and engineering, developments are occurring across the field from lab-based 
research to remote diagnostic use. The development of advanced polarisation resolvable systems 
and cheaper commercially available longer wavelength lasers are enabling the orientation of bone 
matrix components such as collagen to be resolved at larger tissue depths. Raman micro-needle 
based spectroscopic methods have developed by researchers for clinical applications to differentiate 
between healthy and diseased tissues. While the driving force for this has been early detection of 
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cancer in a minimally invasive manner, the identification of a series of characteristic peaks specific 
to early HO or normal or sub-optimal bone healing may form the basis of utilising such technology 
in the clinic in time. 
2.2.6 X-Ray Diffraction (XRD)  
XRD is a technique that provides information on the crystal structure of a sample through 
the illumination of a sample with of a beam of monochromatic X-rays and the analysis of the 
unique pattern of intensity of X-rays scattered over an angular range. Elastic scattering of incident 
X-rays by a crystalline sample occurs because the wavelength of X-rays is comparable to the 
chemical bond lengths and because the atomic arrangement exhibits long range periodic order.[106] 
Importantly, the reflection of X-rays from a crystal plane only occurs when the incident beam is at a 
precise angle to that plane (in this scenario the Bragg condition is satisfied). The detector is moved 
relative to the axis of the beam to detect the summation of radiation diffracted by various 
magnitudes. The degree of crystallinity, size and orientation of crystals, and crystalline chemical 
composition can all be determined by the resulting diffraction pattern. This is of particular interest 
in ossification research as it allows the mineral component of bioengineered or native tissue to be 
analysed. XRD is divided into wide-angle x-ray scattering (WAXS) and small-angle X-ray 
scattering (SAXS), which provide data on atomic and colloidal scale structural regularity 
respectively. The beam of X-rays may be generated by conventional means or by a synchrotron 
facility, which can deliver higher intensity radiation with controlled wavelength distribution, lower 
signal to noise ratio, and ultimately greater analytical sensitivity.[107] In addition to information on 
the identity of crystalline phases within a sample, the Scherrer method may be applied to XRD data 
to allow calculation of fundamental crystallite size and shape.[90, 108] The most common use for 
XRD in mineralisation research is simply to compare the diffraction pattern of bulk samples of 
ectopic bone or engineered mineralised tissue to reference samples of pure HA or normal bone. For 
example, Sabou et al used conventional XRD to compare the mineral phase of ex vivo human HO 
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with that of normal bone and found a high degree of similarity.[109] Similarly, Saito et al used XRD 
to confirm the presence of hydroxyapatite after ectopic implantation of a BMP2-derived peptide 
into a murine model.[54] Synchrotron XRD has been used recently to demonstrate the presence of 
octacalcium phosphate and dicalcium phosphate dihydrate in an osteoblast cell culture model with 
phase evolution into HA.[110] Synchrotron beamline XRD is able to detect smaller quantities of 
crystalline phases in a sample, differentiate more components of mixed samples, and detect 
biological macromolecules. However, for the vast majority of biomineralisation research, laboratory 
XRD is sufficient. 
2.2.7 Multi-photon Spectrometry 
The underlying principles of multiphoton microscopy (MPM) have been understood for 
decades but it is only recently that it has become a commonly used technique in the characterisation 
of biomaterials. The mechanism is that two (or more) long wavelength photons can interact 
simultaneously with electrons in the target sample to elevate them to a higher energy level than 
either could achieve alone.[111] As the electron returns to its resting state, it emits a photon with a 
shorter wavelength (higher energy) than the excitation photons. This is known as the anti-Stokes 
effect. The difference between coherent anti-Stokes Raman spectroscopy (CARS) and standard 
multiphoton imaging is that in CARS, the excitation photons are generated by two different lasers 
and have different wavelengths. By using longer wavelength excitation photons in the near infrared 
spectrum, it is possible to achieve greater fresh tissue penetration (up to 1mm) without any 
preparation or staining.[112] This is due in part to the reduction in autofluorescence of biological 
tissues at these wavelengths. Omelon et al have used MPM to demonstrate the presence of 
polyphosphates in areas of mouse vertebral bone remodelling.[113] This study used a fluorescent dye, 
DAPI, to improve detection of polyphosphates. The differentiation of human adipose-derived stem 
cells into HA-producing osteoblasts has been studied using CARS.[114] Liu et al used MPM to 
characterise their engineered polycarbonate scaffolds and analyse osteoblastic seeding.[115] This 
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study demonstrated how MPM provides greater sample penetration, less photobleaching, and higher 
signal-to-noise ratio than conventional single photon imaging. Villa et al have shown that in vivo 
MPM is possible, by using it to monitor integration and ossification of donor-cell impregnated 
scaffold constructs in mouse calvarial defects.[116] MPM in this study provided three-dimensional 
structural information highlighting the spatial relationships of osteoblasts, scaffold, and deposited 
mineral. Furthermore, this study highlights another feature of MPM, second harmonic generation, 
which can be used to image collagen in situ without any staining or preparation. This means that 
MPM can provide a full picture of the hard and soft components in an in vivo or in vitro 
mineralisation system. 
3 Discussion and Future Directions 
Pathological mineralisation in tissues can cause dysfunction in a broad array of organ systems. 
Its effects are dependent upon the anatomical location and can lead to significant problems as varied 
and serious as heart failure, loss of mobility, and blindness. HO is an outlier in this spectrum of 
disease due to the speed, volume, and degree of hierarchical organisation it displays. This 
fascinating problem is currently the subject of intense research activity relating to the biological 
stimuli and process that cause it. However, the chemical and physical processes occurring at tissue 
level remain comparatively under-investigated. This is surprising given that tissue mechanics and 
chemistry are known be able to drive biological processes and cell differentiation. For example, 
work by Engler and Discher has demonstrated clearly that mesenchymal stem cells can be made to 
follow an osteoblastic lineage purely through the stimulus of a stiff culture substrate.[117] The recent 
rapid advancement of techniques has allowed materials scientists to analyse the physical and 
chemical changes within pathologically mineralised tissue in an unprecedented level of detail. 
Critically, it is through an improved understanding of these material properties that new approaches 
to treating and preventing these conditions will be discovered and refined. For example, if it could 
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be shown that, in HO, calcium phosphate deposition and maturation into its final apatitic phase 
occurs through an alternative pathway to physiological ossification then this may present possible 
therapeutic targets. It might be the case that calcium phosphate phases with higher solubility are 
formed in HO and these could be more amenable to chemical or physiological dispersion. It is only 
through meticulous analysis of the chemical properties of HO tissue as it evolves that the presence 
or absence of such phases could be demonstrated. Another example could involve detailed analysis 
of the microarchitecture of HO using microCT. This approach might allow computer modelling of 
this tissue to help explain why it takes on the characteristically tortuous shapes observed and thus 
reveal mechanistic insights into its pathogenesis. Finally, using microXRF to look for silicon within 
islands of blast injury related HO tissue may provide data to support or refute the hypothesis that 
this condition is stimulated by particles of sand or other foreign material. 
Despite all of the potential benefits that physicochemical analysis of HO tissue may bring, their 
limitations must be acknowledged. The modalities described in this paper are unlikely to ever be 
able to advance our understanding of the upstream biology involved. Meaningful elucidation of the 
complex interplay between tissue damage, inflammation, signalling pathways, and stem cell 
recruitment and differentiation cannot be achieved through observation of the mineral product, no 
matter how careful that observation may be. 
 
Future Clinical Directions 
One example of this could be the use of percutaneous Raman spectroscopy to diagnose HO 
earlier and with more certainty than is currently possible. The Raman laser light and return signal 
could be delivered transcutaneously via optical fibre within a needle to “interrogate” a region 
suspected of developing the disease. If the signal came back showing characteristics of mineral 
where there should only be soft tissue then this would be a strong indicator of HO rather than one of 
the differential diagnoses such as venous thromboembolism or infection. The possibility of using 
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Raman in this way to provide an early and highly reliable diagnosis would enable clinicians to 
target prophylactic therapies to those who needed it rather than exposing entire cohorts of patients 
to the adverse effects of these treatments.  
Another potential use for Raman microscopy in this field may be during surgical excision. 
Once HO has matured into fully mineralised bone-like tissue, it is relatively easy to identify 
intraoperatively. In this case the surgeon can be sure that all of the tissue has been excised. 
However, waiting several months for the tissue to reach this level of maturity will adversely impact 
upon the rehabilitation of the patient. One of the reasons why surgical excision is not undertaken 
earlier is that, in its immature and only partially mineralised state, HO tissue is challenging to 
identify with certainty and the surgeon has to risk either excessive resection of healthy tissue or 
inadequate resection leading to recurrence. This situation is highly analogous to the dilemma faced 
by surgeons excising tumours. However, intraoperative Raman spectroscopy could be used to 
analyse the resection margins for residual immature mineralisation. The surgeon would then be able 
to operate earlier on in the progression of the disease and resect only tissue with developing 
mineralisation. This in turn would enable the patient to start their rehabilitation at an earlier stage 
with all the attendant benefits that this would bring. Given that Raman spectroscopy has already 
been used intraoperatively to confirm resection margins in neurosurgery, there is no conceptual 
reason why this could not be used during HO excision surgery.[118] 
Another potential clinical application for one of these techniques could be in the field of fracture 
healing assessment and non-union diagnosis. MRI elastography could be used to assess the 
mechanical properties of a healing fracture, which is well correlated with the progression of 
healing.[119] 
 
Future Bone Bioengineering Examples 
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Complete structural and compositional characterisation of hard tissues such as bone is a major 
challenge.  In order to properly assess structure using traditional histological methods, it is often 
necessary to process the tissue to remove either the mineral or protein content.  Such processing 
requires chemical treatments that are likely to influence the sample and provide unexpected 
artefacts.  Furthermore, these methods are destructive by nature and so do not allow for the “real-
time” analysis of the forming tissue.  In the case of the growth of bone in vitro this is problematic in 
terms of judging structural changes in the newly forming tissue.  Importantly, if tissue engineering 
approaches are ever to be utilised to grow bone for use in the clinic in place of autogenous bone 
graft, methods must exist that allow for the “quality” of the tissue to be confirmed prior to release 
from the laboratory for use in the clinic.  As such the quantitative and non-destructive methods for 
the physicochemical characterisation of the mineralised tissue are likely to be of paramount 
importance in the coming years.  Structural analysis methods such as micro CT are improving 
rapidly in resolution and are likely to retain a prominent role in the characterisation of ossified 
tissue. Other chemical analysis methods, including Raman microscopy, to some extent micro-XRF 
and MRI all provide spatial chemical information that enables the user to link composition to 
structure. Continuous advances in instrumentation that allow for a reduction in invasiveness and 
tissue damage are likely to make these methods more central to the characterisation of bone that has 
been grown in the lab and importantly critical to translation to the clinic.  
4 Conclusion 
The requirement to analyse physicochemical properties of mineralisation, whether in constructs 
or tissue, is likely to increase in the future. This will be driven by the increasing incidence of 
pathological mineralising conditions such as HO and also by the development of novel bone graft 
substitutes to meet the increasing unmet need.[21, 120] This review has demonstrated that there are 
many techniques available for the analysis of mineralisation. Some of the techniques in use today, 
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such as plain radiography or the Von Kossa staining method, were developed over a hundred years 
ago and have remained largely unchanged since then. Some established techniques have been 
refined or applied in new ways, such as ultrasound or MRI elastography. However, in recent years, 
a wealth of new techniques have been developed that allow for the analysis of mineralised 
structures in entirely new ways and at higher resolution and sensitivity scales than ever before. With 
this wave of innovation, the distinction between clinical and research techniques has also been 
eroded. As a consequence of this expansion and innovation, it is now more important than ever 
before to understand the advantages and disadvantages of each technique in order to chose the most 
appropriate one for the desired application, hence the need for this review. 
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Figure 1. Pathological ossification of various tissues demonstrating the wide anatomical variation 
and a variety of techniques available for analysis. (1.) Cardiac valve mineralisation: backscattered-
scanning electron microscopy analysis of circular cavities: (a) Low magnification image of a 
polished thin section. The brightest areas represent fully mineralised zones. On the left, a massive 
and homogeneous deposit is visible, while in the centre, micrometric circular cavities are visible. (b, 
c) Magnified view of the small cavities indicated in panel (a); fragments of disorganized and 
mineralised collagen are visible within the cavities. Reproduced under the Creative Commons 
Attribution Licence. Copyright © 2015 Valentina Cottignoli et al.[18c] 2015, Hindawi. (2.) (a) 
Multiple osteomata on the upper chest of a patient. (b) Osteoma from the skin of the upper chest of 
the patient in (a), consisting of lamellar bone. Haematoxylin–eosin stain; scale bar = 200 µm. 
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Reproduced with permission.[18h] 2011, Wiley. (3.) Neuritis ossificans: axial magnetic resonance 
fast spoiled gradient recalled with fat saturation (FSPGR FS) images after the administration of 
intravenous gadolinium showing marked enhancement of the tibial (thin white arrow) and common 
peroneal nerves (bold white arrow). Provisional permission to reproduce this figure has been 
granted pending acceptance for publication.[18b]  2011, British Editorial Society of Bone and Joint 
Surgery (4.) Ankylosing spondylitis: schematic drawing showing an overview of a zygapophyseal 
joint section (A). Representative Safranin O–stained sections of human zygapophyseal joints 
demonstrating: normal control (B), osteoarthritis (C), ankylosing spondylitis of increasing severity 
(D), (E), (F). Insets are higher-magnification views of the boxed area in the respective figure. 
Arrows indicate the joint space (either currently existing or its likely previous location). sBP = 
subchondral bone plate; c = cartilage; tb = trabecular bone; bm = bone marrow; ft = fibrous tissue. 
Original magnifications of insets x100 in B–F (top); x400 in F (bottom). Reproduced with 
permission[18f]. 2014, Wiley. 
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Figure 2. Three-dimensional computed tomographic reconstruction of a combat trauma patient who 
has sustained bilateral transfemoral amputations and pelvic disruption with subsequent florid HO 
(arrows). This clearly demonstrates the huge quantities of bone that can form in the soft tissue of 
these cases.  
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Figure 3. SEM images of a sample of combat related HO. (a.) Disordered architecture on the 
micron-to-millimetre scale. Scale bar = 100 µm. (b.) Extensive scalloping suggestive of osteoclastic 
remodelling. Scale bar = 20 µm. 
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Figure 4. Micro CT three-dimensional reconstruction of combat related HO demonstrating 
malformed micro-scale architecture. The arrow demonstrates the two-dimensional cross-sectional 
data revealed by digitally “cutting” the three-dimensional volume. Scale bar = 100 µm. 
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Figure 5. Temporal progression of HO was visualised by near infrared imaging for (A) tenotomy-
only limbs and (B) tenotomy plus burn limbs. (C) Intact contralateral limbs from the burn group, 
which did not form HO, are shown for comparison. This demonstrates that the added injury burden 
provided by the burn potentiated the rapidity of onset of HO. Reproduced with permission.[72] 
2001Wiley. 
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Figure 6. Magnetic resonance imaging: quantitative T2 (A), T1 (B), Poron Density (C), and 
Magnetised Transfer Ratio (D) maps of two poly ethyl methacrylate (PEMA) specimens in a glass 
culture tube filled with saline. The sample at the top was a cell-seeded PEMA sample maintained in 
culture for 7 weeks and the white arrow indicates newly formed bone. The PEMA sample at the 
bottom was not seeded with cells but was included as a control for the imaging experiment. 
Reproduced with permission.[78a] 2004, Wiley. 
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Figure 7. Micro-XRF image of combat related HO. (a.) photomicrograph of sample. (b.) calcium 
mapping. (c.) phosphorus mapping. (d.) colocalisation of calcium and phosphorus. Note the calcium 
rich projections (arrows). 15µm spatial resolution. Scale bar = 400µm. 
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Figure 8. Mapped FTIR images demonstrating the crystallinity (1,030:1,020 cm-1 intensity ratio) in 
BMP-6 supplemented (top) and control (without added BMP-6) cultures (bottom) at days 14 and 
21. All images are presented with the same colour scale. Reproduced with permission[121]. 2001, 
Wiley. 
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Figure 9. Confocal Raman two-dimensional maps showing the spatial distribution of (a) HA (1075 
cm-1), (b) amorphous calcium phosphate (945-952 cm-1), and (c) the amide III bond of collagen 
(1250 cm-1) in a sample of combat related HO. The composite image (d) illustrates the association 
between mineral and collagen within the tissue at the micron scale. Various phases of calcium 
phosphate and collagen can be identified by their distinct peaks within Raman spectra acquired 
point-by-point over the sample. Peaks corresponding to each chemical species can then be gated 
and the sum intensity of those peaks mapped as a function of spatial location to form an image. 
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Table 1. Summary of analytical modalities discussed in this review 
Modality Resolution Information In Vitro, 
In Vivo, 
Ex Vivo 
Destructive Advantages Disadvantages Preparation 
Required 
References 
Histology ~10µm Structure In Vitro 
Ex Vivo 
✓ Cost, widely used, 
minimal specialist 
equipment 
Expertise required to 
interpret images 
Sectioning, fixing, 
and staining 
[17, 33, 48-
49, 51-53, 55-
56, 72]
 
Fluorochrome 
Labelling 
~10µm Structure Ex Vivo ✓ Gives temporal 
information about new 
bone formation. Can be 
used for longitudinal 
analysis if multiple 
administrations 
Need to wait for 
fluorochrome label 
to be incorporated 
into newly formed 
bone 
Fluorochrome 
administration, 
sectioning, and 
fixing 
[56, 72]
 
Transmission 
Electron Microscopy 
Angstroms Structure Ex Vivo 
In Vitro 
✓ Resolution Two-dimensional 
projection of three-
dimensional 
structure 
Embedding and 
sectioning 
[60a, 91, 122]
 
Scanning Electron 
Microscopy 
~1nm Structure Ex Vivo 
In Vitro 
✓ Depth of field 
Resolution 
Technically 
demanding at very 
high magnification 
Coating of sample [17, 52d, 62-
63, 95]
 
Plain Radiography ~1mm Structure In Vivo X Cost 
Availability 
Simplicity 
Ionising 
Delay to diagnosis 
Nil [34, 57-58]
 
Microradiography ~10µm Structure In Vitro 
Ex Vivo 
✓ Cost Limited information Embedding, 
sectioning 
[17, 59]
 
Micro CT ~1µm Structure In Vitro 
Ex Vivo 
In Vivo 
X Rapid 
Allows longitudinal 
analysis in vivo 
3-dimensional dataset 
Ionising 
Highest resolution 
not safe in vivo 
Nil [52b, 52c, 
53a, 54, 62, 
67-68]  
Isotope Bone Scan ~1cm Structure In Vivo X Early In Vivo detection Non-specific 
Ionising 
Radioisotope 
administration 
[69a]
 
Near Infra-Red 
Fluorescence 
~1mm Structure In Vivo X Gives information on 
process of mineralisation 
Relatively poor 
spatial resolution 
Administration of 
IR dye 
[70-72]
 
MRI ~100µm Structure 
Elastography 
In Vivo 
In Vitro 
X Provides multimodal 
data 
Requires highly 
specialised 
equipment 
Nil for structural 
information 
Mechanical 
vibration for 
elastography 
[73-81, 83]
 
Ultrasound ~25µm Structure 
Composition 
Elastography 
In Vivo 
In Vitro 
X Cheap, safe, real-time, 
multimodal information 
User dependent Nil for structural 
information 
[84-86, 88-
89]
 
Energy Dispersive X-
ray Spectrometry 
~1µm3 Composition In Vitro X Elemental analysis 
 
Low efficiency at 
exciting x-ray 
fluorescence 
Slow scan speeds [53b, 123]
 
X-Ray Fluorescence 
Spectrometry 
 
10µm Composition In Vitro 
Ex Vivo 
✓/X Femtogram quantities of 
elements detectable 
Requires access to 
synchrotron for 
highest resolution 
data 
Pellet formation 
for bulk XRF, 
embedding for 
mapping 
 
[2, 96]
 
Fourier Transform 
Infrared Spectroscopy 
(FT-IS) 
 
~10µm 
(1.3µm using 
synchrotron) 
Composition Ex Vivo 
In Vitro 
 
X Chemical bond analysis Requires access to 
synchrotron for 
highest resolution 
data 
Nil [67, 99, 101, 
121, 124]
 
Raman Spectroscopy ~1µm Composition Ex Vivo 
In Vivo 
In Vitro 
X Non destructive 
No sample preparation 
Safe in vivo 
Very large datasets 
when imaging 
volumes 
Nil [52a, 52b, 87, 
102-103, 105]
 
X-Ray Diffraction 
(XRD) 
Atomic 
(WAXS) 
 
Composition Ex Vivo 
In Vivo 
✓/X Can identify mineral 
species present  
Not suitable for live 
cells/tissue 
Ionising radiation 
Destructive at higher 
beam energies 
Grind sample to 
powder 
[53b, 106-
107, 109-110]
 
Multi-photon ~0.1µm3 Structure 
Composition 
Ex Vivo 
In Vitro 
In Vivo 
X Tissue penetration 
Resolution 
High signal to noise ratio 
Technically 
challenging 
Photodamage 
Fluorescent 
labelling if needed 
Untreated samples 
can be used 
[111-112, 
114-116]
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